Several cytokines, including CCL21 through the activation of CCR7 (80, 81), CCL5 and CXCL10 (82), have been implicated in metastatic lymphangiogenesis as well as the formation and maintenance of CLR and other tumor-specific immune responses. Here, DCLK3 is linked to neoplasm.